WASHINGTON (MedPage Today) — This week, President Obama signed a much-wrangled-over bill to raise the debt ceiling after Congress finally passed a measure to prevent the U.S. from defaulting on its loans. Then the lawmakers left town for the August recess.
No Comments »
Filed under: General Health News
(MedPage Today) — American Regent has recalled a number of lots of its injectable vasopressin because it may lose potency during the product’s shelf life.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The FDA has issued a Class I recall on a humidification device used during mechanical ventilation because possible occlusion may stem the flow of oxygen to the patient.
No Comments »
Filed under: General Health News
(MedPage Today) — Texas Gov. Rick Perry received an injection of his own stem cells during spinal fusion surgery last month and wants his state to be a leader in the use of adult stem cells in medical treatment.
No Comments »
Filed under: General Health News
(MedPage Today) — American Regent has recalled a number of lots of its injectable vasopressin because it may lose potency during the product’s shelf life.
No Comments »
Filed under: Pharmacy News
WASHINGTON (MedPage Today) — The FDA has issued a Class I recall on a humidification device used during mechanical ventilation because possible occlusion may stem the flow of oxygen to the patient.
No Comments »
Filed under: Pharmacy News
VIVUS, Inc. today announced that additional data from the phase 3 QNEXA studies will be presented today during the American Association of Diabetes Educators (AADE) meeting in Las Vegas, NV.
No Comments »
Filed under: Pharmacy News
VIVUS, Inc. (NASDAQ: VVUS) announced that additional data from the phase 3 QNEXA studies will be presented during the American Association of Diabetes Educators (AADE) meeting in Las Vegas, NV. Ronette L…
No Comments »
Filed under: Pharmacy News
Healthpoint Biotherapeutics announced positive topline results for its Phase IIb clinical trial investigating the efficacy of HP802-247 in venous leg ulcers. HP802-247 is an investigational allogeneic living cell suspension containing keratinocytes and fibroblasts…
No Comments »
Filed under: Pharmacy News
Intelliject, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted tentative approval for the company’s New Drug Application (NDA) for a novel epinephrine auto-injector, e-cue™, for emergency treatment of allergic reactions including anaphylaxis…
No Comments »
Filed under: Pharmacy News
